HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

48.000

-0.440-0.91%

Volume:7.08M

Turnover:338.60M

Market Cap:318.58B

PE:34.69

High:49.100

Open:48.980

Low:46.480

Close:48.440

52wk High:88.043

52wk Low:43.020

Shares:6.64B

HK Float Shares:258.00M

Volume Ratio:1.86

T/O Rate:2.75%

Dividend:0.23

Dividend Rate:0.49%

EPS(LYR):1.384

ROE:12.46%

ROA:7.02%

PB:4.21

PE(LYR):34.69

PS:8.67

Loading ...

Overview Company News Filings

HK Movers | Pharma Stocks Jump With CanSino Biologics up 19%, Joinn Laboratories up 17%

Tiger Newspress

Movement Alert｜HENGRUI PHARMA Rises 3.33% in Regular Trading, Novo Nordisk Licensing Deal Worth Up to $2.6 Billion Continues to Fuel Rally

Hong Kong Stock Connect Innovative Drug Sector Defies Market Downturn as Top Pharmaceutical Firm Enters with US$2 Billion, Akeso Surges 15.54%, Hengrui Pharma Secures US$2.6 Billion BD Deal

Novo Nordisk Strikes Second Licensing Deal Since Frosty Capital-Markets Day

HENGRUI PHARMA: BlackRock, Inc. Disposes of Shares, Long Position Falls to 6.96%

Hengrui Pharma Licenses Oral GLP-1/GIP Weight-Loss Drug to Novo Nordisk in Deal Worth Up to $2.6 Billion

China's Hengrui Inks up to $2.6 Billion Deal with Novo Nordisk for Obesity Drug

Hengrui Pharma and Novo Nordisk Sign Licensing Agreement for HRS-1596 Project

Hengrui Pharma Inks Up to USD 2.60 Billion Global Licence Deal with Novo Nordisk for Oral GLP-1/GIP Agonist HRS-1596

Bulletin Express

Jiangsu Hengrui Pharmaceuticals - Entering into License Agreement for Hrs-1596 with Novo Nordisk a/S

THOMSON REUTERS

Jiangsu Hengrui Pharmaceuticals - Potential Total Value of Agreement up to $2.6 Bln Contingent on Achievement of Applicable Development, Others

THOMSON REUTERS

Jiangsu Hengrui Pharmaceuticals - Dedal Includes $300 Mln Upfront Payment

THOMSON REUTERS

Jiangsu Hengrui Pharmaceuticals - Co Also Eligible to Receive Royalties Based on Net Sales of Hrs-1596 Within Licensed Territory

THOMSON REUTERS

Movement Alert｜HENGRUI PHARMA Rises 3.57% in Regular Trading, Multiple Global Institutions Accumulate Shares Amid Accelerated Drug Approvals

Blackrock's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 7.32%, Says HKEX

UBS Group Ag's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 5.23% on Sept 21 from 4.43% - HKEX

THOMSON REUTERS

HENGRUI PHARMA: UBS Group AG Acquires Shares, Long Position Rises to 5.23%

HENGRUI PHARMA: BlackRock, Inc. Acquires Shares, Long Position Rises to 7.32%

HENGRUI PHARMA: BlackRock, Inc. Disposes of Shares, Long Position Falls to 6.7%

HENGRUI PHARMA: GIC Private Limited Disposes of Shares, Long Position Falls to 16.92%

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.etasphere.com/stock/01276/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":48,"timestamp":1791533288000,"preClose":48.44,"halted":0,"volume":7084600,"delay":0,"changeRate":-0.009083402146985916,"floatShares":258000000,"shares":6637000000,"eps":1.3837561316349194,"marketStatus":"Market Closed","change":-0.44,"latestTime":"10-09 16:08:08","open":48.98,"high":49.1,"low":46.48,"amount":338603291,"amplitude":0.054088,"askPrice":48,"askSize":1600,"bidPrice":47.98,"bidSize":800,"shortable":3,"etf":0,"ttmEps":1.364629807476474,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791768600000},"marketStatusCode":7,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":48.44,"dividendRate":0.004874,"openAndCloseTimeList":[[1791509400000,1791518400000],[1791522000000,1791532800000]],"volumeRatio":1.8649424306576454,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":46.85,"timestamp":1791529200000,"preClose":47.01,"halted":0,"volume":62812700,"delay":0,"premium":"-12.63"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":258000000,"roa":"7.02%","roe":"12.46%","lyrEps":1.383756,"volumeRatio":1.8649424306576454,"shares":6637000000,"dividePrice":0.234535,"high":49.1,"amplitude":0.054088,"preClose":48.44,"low":46.48,"week52Low":43.02,"pbRate":"4.21","psRate":"8.67","week52High":88.043,"institutionHeld":0,"latestPrice":48,"committee":-0.333333,"eps":1.3837561316349194,"divideRate":0.004886,"volume":7084600,"delay":0,"ttmEps":1.364629807476474,"open":48.98,"prevYearClose":71.002,"prevWeekClose":49.66,"prevMonthClose":50.2,"prevQuarterClose":50.2,"fiveDayClose":49.66,"twentyDayClose":43.96,"sixtyDayClose":57.95,"earningDate":1793116800000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[{"date":"2026-10-28","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1793151000000,"name":null,"time":"","dateTimestamp":1793116800000,"actualEps":null},{"date":"2026-08-19","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-04-29","symbol":"01276","amount":0.22828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-04-30","defaultRemindTime":1777426200000,"name":"恒瑞医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-27","payableDate":"2026-04-30","currency":"HKD","dateTimestamp":1777392000000,"payDate":"2026-05-27"},{"date":"2026-04-22","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776821400000,"name":null,"time":"","dateTimestamp":1776787200000,"actualEps":null},{"date":"2026-03-26","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[{"executeDate":"2026-04-29","recordDate":"2026-04-30","paymentDate":"2026-05-27","value":0.22828,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5455,"hold":0.1818,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1786723200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2026-10-09","current":35.174375,"percent":0.119883,"low":36.382401,"twenty":42.857544,"median":51.138757,"eighty":56.781666,"high":65.582363,"avg":50.516449,"sd":7.729997,"marketCap":361173641492.57},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53},{"date":"2025-05-30","current":53.015805,"twenty":51.822085,"median":52.540895,"eighty":52.926837,"marketCap":395731540422.24},{"date":"2025-06-06","current":52.120101,"twenty":52.130014,"median":52.555929,"eighty":53.075252,"marketCap":390038198012.59},{"date":"2025-06-13","current":52.209491,"twenty":52.177631,"median":52.691227,"eighty":53.357137,"marketCap":390861633032.23},{"date":"2025-06-20","current":50.172412,"twenty":51.591196,"median":52.469796,"eighty":53.075252,"marketCap":374874997562.85},{"date":"2025-06-27","current":50.314776,"twenty":50.363569,"median":52.169666,"eighty":53.013533,"marketCap":376991477472.78},{"date":"2025-07-04","current":51.666141,"twenty":50.343584,"median":52.120101,"eighty":53.004446,"marketCap":387134991658.26},{"date":"2025-07-11","current":55.507007,"twenty":50.44351,"median":52.13337,"eighty":53.090114,"marketCap":415495681161.23},{"date":"2025-07-18","current":57.272274,"twenty":50.582121,"median":52.209491,"eighty":54.057606,"marketCap":428373566715.29},{"date":"2025-07-25","current":54.897923,"twenty":50.594414,"median":52.555929,"eighty":55.711415,"marketCap":412107620053.2},{"date":"2025-08-01","current":59.731878,"twenty":50.855059,"median":52.994419,"eighty":55.972407,"marketCap":445624526286.47},{"date":"2025-08-08","current":59.478715,"twenty":51.107295,"median":53.05296,"eighty":56.541585,"marketCap":444845815775.64},{"date":"2025-08-15","current":61.917611,"twenty":51.356483,"median":53.519848,"eighty":59.478715,"marketCap":462392609292.46},{"date":"2025-08-22","current":58.782188,"twenty":51.569512,"median":54.477764,"eighty":60.15932,"marketCap":470428104569.66},{"date":"2025-08-29","current":59.85298,"twenty":51.666141,"median":55.691374,"eighty":59.937003,"marketCap":481284287403.35},{"date":"2025-09-05","current":65.582363,"twenty":51.677932,"median":55.770266,"eighty":60.732448,"marketCap":526832269752.24},{"date":"2025-09-12","current":62.481332,"twenty":51.8337,"median":55.972407,"eighty":61.285609,"marketCap":502824785657.99},{"date":"2025-09-19","current":63.179889,"twenty":52.120101,"median":56.254853,"eighty":61.852995,"marketCap":508085671393.42},{"date":"2025-09-26","current":63.528382,"twenty":52.146639,"median":56.965096,"eighty":62.270337,"marketCap":509562668601.01},{"date":"2025-10-03","current":64.989073,"twenty":52.165061,"median":57.272274,"eighty":62.504861,"marketCap":522523002865.02},{"date":"2025-10-10","current":61.782766,"twenty":52.193561,"median":59.039802,"eighty":62.657943,"marketCap":496019912951.91},{"date":"2025-10-17","current":58.903713,"twenty":52.323014,"median":59.170669,"eighty":62.619084,"marketCap":472537436949.31},{"date":"2025-10-24","current":59.187086,"twenty":52.484015,"median":59.039802,"eighty":62.52839,"marketCap":474983377696.11},{"date":"2025-10-31","current":57.072441,"twenty":52.552922,"median":59.021138,"eighty":62.417499,"marketCap":465758305542.93},{"date":"2025-11-07","current":54.713071,"twenty":52.619069,"median":58.881843,"eighty":62.304573,"marketCap":446224987036.64},{"date":"2025-11-14","current":55.883072,"twenty":52.812504,"median":58.231971,"eighty":62.27542,"marketCap":457058673340.29},{"date":"2025-11-21","current":52.805265,"twenty":52.880927,"median":57.030538,"eighty":62.209511,"marketCap":431684582485.14},{"date":"2025-11-28","current":55.237621,"twenty":52.99843,"median":56.630614,"eighty":62.069705,"marketCap":453209419829.34},{"date":"2025-12-05","current":54.841023,"twenty":53.00899,"median":56.437545,"eighty":61.965159,"marketCap":450729029423.46},{"date":"2025-12-12","current":56.212257,"twenty":53.045529,"median":56.385682,"eighty":61.891765,"marketCap":462853512587.19},{"date":"2025-12-19","current":54.083493,"twenty":53.045529,"median":56.227363,"eighty":61.831221,"marketCap":446374731108.34},{"date":"2025-12-24","current":54.414957,"twenty":53.090114,"median":56.103073,"eighty":61.798561,"marketCap":450509359276.9},{"date":"2026-01-02","current":53.078544,"twenty":53.065996,"median":55.972407,"eighty":61.785925,"marketCap":441174507319.22},{"date":"2026-01-09","current":56.743223,"twenty":53.0878,"median":56.0944,"eighty":61.695241,"marketCap":472808676524.34},{"date":"2026-01-16","current":55.187351,"twenty":53.304215,"median":56.103073,"eighty":61.405393,"marketCap":461338821289.95},{"date":"2026-01-23","current":52.546341,"twenty":53.0878,"median":56.076447,"eighty":61.296167,"marketCap":438839874056.97},{"date":"2026-01-30","current":51.677141,"twenty":52.994149,"median":55.908509,"eighty":61.278475,"marketCap":433553740508.2},{"date":"2026-02-06","current":50.918226,"twenty":52.680723,"median":55.839154,"eighty":61.101743,"marketCap":428270226283.58},{"date":"2026-02-13","current":51.771686,"twenty":52.512455,"median":55.711415,"eighty":60.890064,"marketCap":437949787160.49},{"date":"2026-02-20","current":51.752043,"twenty":52.351169,"median":55.691374,"eighty":60.824953,"marketCap":437153052005.04},{"date":"2026-02-27","current":50.215456,"twenty":52.151244,"median":55.507566,"eighty":60.720339,"marketCap":428825318404.97},{"date":"2026-03-06","current":49.335298,"twenty":51.80347,"median":55.280584,"eighty":60.654676,"marketCap":417912584744.19},{"date":"2026-03-13","current":48.90444,"twenty":51.75217,"median":55.201025,"eighty":60.572606,"marketCap":416170839186.33},{"date":"2026-03-20","current":48.948437,"twenty":51.671435,"median":55.086674,"eighty":60.515374,"marketCap":414967977646.95},{"date":"2026-03-27","current":47.483832,"twenty":51.400677,"median":54.94883,"eighty":60.443129,"marketCap":414588875872.42},{"date":"2026-04-02","current":49.302243,"twenty":51.107295,"median":54.905743,"eighty":60.227005,"marketCap":432534434303.11},{"date":"2026-04-10","current":49.055344,"twenty":50.995993,"median":54.897923,"eighty":60.186394,"marketCap":433687668394.36},{"date":"2026-04-17","current":48.417764,"twenty":50.589497,"median":54.65026,"eighty":60.143018,"marketCap":428230701835.75},{"date":"2026-04-24","current":45.835792,"twenty":50.342877,"median":54.475147,"eighty":60.015062,"marketCap":426879682872.04},{"date":"2026-04-30","current":44.026312,"twenty":50.285416,"median":54.355253,"eighty":59.903394,"marketCap":410132737659.64},{"date":"2026-05-08","current":43.161515,"twenty":50.207478,"median":54.262074,"eighty":59.804539,"marketCap":403472171949.3},{"date":"2026-05-15","current":44.128138,"twenty":49.985706,"median":54.115335,"eighty":59.70386,"marketCap":413593092820.6},{"date":"2026-05-22","current":41.244553,"twenty":49.583265,"median":53.983854,"eighty":59.631568,"marketCap":385683097978.4},{"date":"2026-05-29","current":40.98659,"twenty":49.34142,"median":53.840414,"eighty":59.564678,"marketCap":384603594259.51},{"date":"2026-06-05","current":38.394132,"twenty":49.063316,"median":53.633194,"eighty":59.459458,"marketCap":360799766229.36},{"date":"2026-06-12","current":39.515262,"twenty":48.81081,"median":53.517715,"eighty":59.36625,"marketCap":371084155232.86},{"date":"2026-06-18","current":39.444808,"twenty":48.417764,"median":53.467699,"eighty":59.301536,"marketCap":371311256576.18},{"date":"2026-06-26","current":39.60241,"twenty":47.951326,"median":53.090114,"eighty":59.187086,"marketCap":370974287810.31},{"date":"2026-07-03","current":44.319925,"twenty":47.638943,"median":53.015805,"eighty":59.069259,"marketCap":415476044901.86},{"date":"2026-07-10","current":45.319748,"twenty":47.348429,"median":52.993744,"eighty":59.024871,"marketCap":424327469311.14},{"date":"2026-07-17","current":43.189222,"twenty":46.151454,"median":52.805265,"eighty":58.96135,"marketCap":405818502739.33},{"date":"2026-07-24","current":43.433009,"twenty":45.632553,"median":52.604835,"eighty":58.912251,"marketCap":408200902707.63},{"date":"2026-07-31","current":43.935338,"twenty":45.29749,"median":52.543618,"eighty":58.877468,"marketCap":413706414238.87},{"date":"2026-08-07","current":44.394532,"twenty":45.008473,"median":52.339287,"eighty":58.813302,"marketCap":418841988303.56},{"date":"2026-08-14","current":42.6704,"twenty":44.628794,"median":52.189578,"eighty":58.452058,"marketCap":403085247281.44},{"date":"2026-08-21","current":40.686911,"twenty":44.408765,"median":52.120101,"eighty":57.75211,"marketCap":366558497066.13},{"date":"2026-08-28","current":40.334802,"twenty":44.24321,"median":51.814807,"eighty":57.336246,"marketCap":363468645736.13},{"date":"2026-09-04","current":39.220129,"twenty":44.050964,"median":51.771686,"eighty":57.152374,"marketCap":353565883607.49},{"date":"2026-09-11","current":36.382401,"twenty":43.912617,"median":51.717719,"eighty":57.022157,"marketCap":328426636361.34},{"date":"2026-09-18","current":37.472943,"twenty":43.707258,"median":51.677141,"eighty":56.974512,"marketCap":338713028678.65},{"date":"2026-09-25","current":38.226655,"twenty":43.43262,"median":51.617827,"eighty":56.891919,"marketCap":344867204477.93},{"date":"2026-10-02","current":40.279147,"twenty":43.172598,"median":51.438629,"eighty":56.828798,"marketCap":363767175425.28},{"date":"2026-10-09","current":39.942129,"twenty":42.857544,"median":51.138757,"eighty":56.781666,"marketCap":361173641492.57}],"updateTime":1791663704747},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01276\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1125539340","title":"HK Movers | Pharma Stocks Jump With CanSino Biologics up 19%, Joinn Laboratories up 17%","url":"https://stock-news.laohu8.com/highlight/detail?id=1125539340","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125539340?lang=en_us&edition=fundamental","pubTime":"2026-09-30 13:40","pubTimestamp":1790746819,"startTime":"0","endTime":"0","summary":"Hong Kong's biopharmaceutical sector rallied across the board, with $CANSINOBIO(06185)$ surging over 19%, $LAEKNA-B(02105)$ jumping more than 18%, and  $GENSCRIPT BIO(01548)$ rising nearly 9% to a new high. $EVEREST MED(01952)$ rose 6%, $XTALPI(02228)$ gained more than 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"330240692f324d079ccf839d9e4180bf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548","06127","01276","03696","06185","02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163813448","title":"Movement Alert｜HENGRUI PHARMA Rises 3.33% in Regular Trading, Novo Nordisk Licensing Deal Worth Up to $2.6 Billion Continues to Fuel Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1163813448","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163813448?lang=en_us&edition=fundamental","pubTime":"2026-09-30 10:03","pubTimestamp":1790733822,"startTime":"0","endTime":"0","summary":"On September 30, HENGRUI PHARMA rose 3.33% in regular trading, trading at HKD 47.14/share, with turnover of HKD 61.00 million, extending gains from the previous session as the market continued to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173705860","title":"Hong Kong Stock Connect Innovative Drug Sector Defies Market Downturn as Top Pharmaceutical Firm Enters with US$2 Billion, Akeso Surges 15.54%, Hengrui Pharma Secures US$2.6 Billion BD Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1173705860","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173705860?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:20","pubTimestamp":1790680850,"startTime":"0","endTime":"0","summary":"On September 29, the Hong Kong stock market retreated, but innovative drugs led gains against the broader trend. The Hang Seng Stock Connect Innovative Drug ETF (520880) tracking index, with 100%...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2778985437.USD","LU0405327494.USD","LU2488822045.USD","BK1191","LU2476274308.USD","LU0405327148.USD","09926","LU0359202008.SGD","LU0417516902.SGD","LU0348825331.USD","LU1064130708.USD","BK0028","LU2097828557.USD","01276","MEDX","LU0348766576.USD","LU1720050803.USD","LU2399975544.HKD","600276","LU0417516738.SGD","LU1655091616.SGD","LU1969619763.USD","LU2097828714.EUR","06978","BK0239","LU0561508036.HKD","LU0348827113.USD","LU0634319403.HKD","LU1997245094.SGD","LNGR","LU0348735423.USD","LU2328871848.SGD","LU1961090484.USD","BK1161","KURE","LU1580142542.USD","LU2097828805.USD","BK0183","LU0540923850.HKD","LU1820825898.SGD","IE00B543WZ88.USD","LU1023057109.AUD","LU2543165471.USD","LU0348783233.USD","LU0417516571.SGD","LU1146622755.USD","LU1997245177.USD","LU2289578879.USD","LU1064131003.USD","IBBQ","LU1997244956.HKD","LU2097828474.EUR","LU2148510915.USD","FLHK","BK0188","LU0359201612.USD","LU0359201885.HKD","LU1794554557.SGD","LU2580892789.USD","LU1255011170.USD","LU1328615791.USD","LU2097828631.EUR","LU2495084118.USD","LU1781817850.SGD","LU2580892862.HKD","159992","BK0060","BK0012","LU0348767384.USD","LU0348784397.USD","IE00BPRC5H50.USD","BK0196","LU2476274720.SGD","BK1574","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671218563","title":"Novo Nordisk Strikes Second Licensing Deal Since Frosty Capital-Markets Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2671218563","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671218563?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:46","pubTimestamp":1790675160,"startTime":"0","endTime":"0","summary":"Danish drugmaker to pay up to $2.6 billion for Chinese obesity pill candidateNovo Nordisk struck a licensing deal.Novo Nordisk on Tuesday struck its second licensing deal since receiving a poor recept","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","BK1191","LU1093756325.SGD","BK4007","LU1093756168.USD","OZEM","01276","LU0359201885.HKD","LU2543165471.USD","BK4588","IE00BKVL7J92.USD","BK4585","NVOC","600276","NVO","THNR","BK4532","LU0359202008.SGD","LU1023057109.AUD","NVOX","IE00BZ1G4Q59.USD","LU0154236417.USD","LU0359201612.USD","PPH","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142578591","title":"HENGRUI PHARMA: BlackRock, Inc. Disposes of Shares, Long Position Falls to 6.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=1142578591","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142578591?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:32","pubTimestamp":1790674347,"startTime":"0","endTime":"0","summary":"On September 24, 2026, BlackRock, Inc. sold 490,600 shares of HENGRUI PHARMA (01276) on the SEHK open market at an average of HKD 47.4810 per share, involving about HKD 23.29 million. This was an...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120980647","title":"Hengrui Pharma Licenses Oral GLP-1/GIP Weight-Loss Drug to Novo Nordisk in Deal Worth Up to $2.6 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1120980647","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120980647?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:28","pubTimestamp":1790659697,"startTime":"0","endTime":"0","summary":"Hengrui Pharma has licensed its self-developed oral GLP-1/GIP dual receptor agonist HRS-1596 to global weight-loss drug leader Novo Nordisk, with a potential total deal value of up to $2.6 billion,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828557.USD","LU2097828631.EUR","JDOC","LU0359202008.SGD","LU0405327494.USD","LU2289578879.USD","LU2148510915.USD","LU2580892789.USD","LU1064131003.USD","LU2097828714.EUR","LU0405327148.USD","LU1064130708.USD","BK0012","LU2097828805.USD","LU2543165471.USD","LU1997244956.HKD","BK0188","BK1191","LU0359201885.HKD","LU1655091616.SGD","LU1997245177.USD","LU2097828474.EUR","LU1146622755.USD","LU2488822045.USD","LU1820825898.SGD","LU2495084118.USD","LU2580892862.HKD","LU1997245094.SGD","BK0028","BK0060","LU0359201612.USD","LU1781817850.SGD","LU1969619763.USD","LU2328871848.SGD","LU1255011170.USD","BK0183","BK0196","BK0239","LU1023057109.AUD","BGIA","01276","LU1580142542.USD","600276","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671298568","title":"China's Hengrui Inks up to $2.6 Billion Deal with Novo Nordisk for Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2671298568","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671298568?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:10","pubTimestamp":1790658607,"startTime":"0","endTime":"0","summary":"Sept 29 (Reuters) - Jiangsu $Hengrui Pharmaceuticals(01276)$, China's largest drugmaker by ‌market value, said on Tuesday it will license global rights to ⁠its weight-management drug HRS-1596 to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nL4N45L0BV:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"China's Hengrui Inks up to $2.6 Billion Deal with Novo Nordisk for Obesity Drug","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","LU2580892789.USD","LU0405327148.USD","LU1969619763.USD","NVOX","600276","LU1781817850.SGD","BK0028","LU2097828474.EUR","LU1820825898.SGD","BK0188","LU1997245177.USD","LU0405327494.USD","LU1655091616.SGD","LU2097828557.USD","LU2580892862.HKD","BK0012","NVOC","LU2097828631.EUR","LU2488822045.USD","BK0060","LU1255011170.USD","BK0239","LU2328871848.SGD","NVOH","LU2148510915.USD","BK0196","LU1997244956.HKD","LU1064131003.USD","LU1328615791.USD","LU1997245094.SGD","LU2289578879.USD","NVO","LU1064130708.USD","LU2097828805.USD","LU1146622755.USD","01276","LU2495084118.USD","LU1580142542.USD","LU2097828714.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107831327","title":"Hengrui Pharma and Novo Nordisk Sign Licensing Agreement for HRS-1596 Project","url":"https://stock-news.laohu8.com/highlight/detail?id=1107831327","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107831327?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:49","pubTimestamp":1790657347,"startTime":"0","endTime":"0","summary":"Hengrui Pharma (600276.SH) announced that the company has entered into an agreement with Novo Nordisk A/S to license its potential once-weekly oral GLP-1 and GIP dual receptor agonist HRS-1596 to...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828557.USD","LU1655091616.SGD","LU1997245177.USD","LU2495084118.USD","LU2097828474.EUR","BK0196","LU1146622755.USD","LU1328615791.USD","LU1820825898.SGD","LU2148510915.USD","LU0405327494.USD","LU1997245094.SGD","LU2328871848.SGD","LU2289578879.USD","LU1064130708.USD","LU2097828714.EUR","BK4588","NVO","LU1969619763.USD","NVOH","BK0183","LU2580892862.HKD","PPH","NVOX","NVOC","LU2488822045.USD","BK4585","LU1064131003.USD","LU2580892789.USD","01276","BK0028","LU0405327148.USD","LU1255011170.USD","BK4599","BK0239","BK0188","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK0060","LU0154236417.USD","LU1997244956.HKD","LU1781817850.SGD","LU2097828631.EUR","LU1580142542.USD","OZEM","BK0012","BK4532","BK4007","LU1093756325.SGD","600276","LU1093756168.USD","LU2097828805.USD","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129213065","title":"Hengrui Pharma Inks Up to USD 2.60 Billion Global Licence Deal with Novo Nordisk for Oral GLP-1/GIP Agonist HRS-1596","url":"https://stock-news.laohu8.com/highlight/detail?id=1129213065","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129213065?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:42","pubTimestamp":1790656952,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) has signed a licence agreement with Novo Nordisk A/S granting Novo exclusive rights to develop, manufacture and commercialise the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671260728","title":"Jiangsu Hengrui Pharmaceuticals - Entering into License Agreement for Hrs-1596 with Novo Nordisk a/S","url":"https://stock-news.laohu8.com/highlight/detail?id=2671260728","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671260728?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:28","pubTimestamp":1790656131,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L00A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0183","LU0359201612.USD","LU1064131003.USD","LU0405327148.USD","BK0188","LU1997245094.SGD","LU2488822045.USD","BK0028","LU1820825898.SGD","BK0196","LU1655091616.SGD","LU0359201885.HKD","LU1146622755.USD","BK0060","LU2328871848.SGD","LU2148510915.USD","LU2097828714.EUR","LU1023057109.AUD","01276","LU1255011170.USD","LU1969619763.USD","LU2097828474.EUR","LU2580892789.USD","600276","LU1580142542.USD","LU1781817850.SGD","BK0239","LU2097828557.USD","LU0405327494.USD","LU2543165471.USD","BK0012","LU2097828631.EUR","LU2580892862.HKD","LU1997244956.HKD","LU1997245177.USD","LU2289578879.USD","LU0359202008.SGD","LU2097828805.USD","LU1064130708.USD","LU2495084118.USD","LU1328615791.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671260724","title":"Jiangsu Hengrui Pharmaceuticals - Potential Total Value of Agreement up to $2.6 Bln Contingent on Achievement of Applicable Development, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2671260724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671260724?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:28","pubTimestamp":1790656131,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L00A:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2148510915.USD","BK0239","LU0359202008.SGD","LU1023057109.AUD","LU0405327494.USD","LU2495084118.USD","LU1781817850.SGD","LU1997245177.USD","LU1820825898.SGD","LU1655091616.SGD","LU2097828631.EUR","LU2097828805.USD","LU1064131003.USD","LU2097828474.EUR","LU2097828557.USD","LU2543165471.USD","BK0188","LU0359201885.HKD","BK0060","LU2328871848.SGD","LU0405327148.USD","BK0196","LU1580142542.USD","LU2580892862.HKD","BK0028","LU1997244956.HKD","LU1146622755.USD","LU1255011170.USD","BK1191","BK0012","BK0183","01276","LU1997245094.SGD","LU1064130708.USD","LU0359201612.USD","600276","LU2488822045.USD","LU2580892789.USD","LU1969619763.USD","LU2289578879.USD","LU1328615791.USD","LU2097828714.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671260048","title":"Jiangsu Hengrui Pharmaceuticals - Dedal Includes $300 Mln Upfront Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2671260048","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671260048?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:28","pubTimestamp":1790656131,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L00A:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0196","LU1255011170.USD","LU2289578879.USD","LU2488822045.USD","LU1781817850.SGD","LU2097828631.EUR","LU2097828714.EUR","LU1997245177.USD","LU2328871848.SGD","BK0012","LU2580892862.HKD","LU1328615791.USD","LU1064130708.USD","LU2097828805.USD","BK1191","LU1997245094.SGD","LU2495084118.USD","BK0028","BK0060","LU0405327494.USD","LU2148510915.USD","LU1655091616.SGD","LU1146622755.USD","LU0359201612.USD","LU1997244956.HKD","600276","BK0188","LU0359202008.SGD","LU1969619763.USD","LU0359201885.HKD","LU2580892789.USD","LU2543165471.USD","LU1580142542.USD","LU1820825898.SGD","LU2097828557.USD","LU2097828474.EUR","LU1023057109.AUD","LU1064131003.USD","BK0183","LU0405327148.USD","01276","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671126001","title":"Jiangsu Hengrui Pharmaceuticals - Co Also Eligible to Receive Royalties Based on Net Sales of Hrs-1596 Within Licensed Territory","url":"https://stock-news.laohu8.com/highlight/detail?id=2671126001","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671126001?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:28","pubTimestamp":1790656131,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L00A:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0196","LU1255011170.USD","LU2289578879.USD","LU2488822045.USD","LU1781817850.SGD","LU2097828631.EUR","LU2097828714.EUR","LU1997245177.USD","LU2328871848.SGD","BK0012","LU2580892862.HKD","LU1328615791.USD","LU1064130708.USD","LU2097828805.USD","BK1191","LU1997245094.SGD","LU2495084118.USD","BK0028","BK0060","LU0405327494.USD","LU2148510915.USD","LU1655091616.SGD","LU1146622755.USD","LU0359201612.USD","LU1997244956.HKD","600276","BK0188","LU0359202008.SGD","LU1969619763.USD","LU0359201885.HKD","LU2580892789.USD","LU2543165471.USD","LU1580142542.USD","LU1820825898.SGD","LU2097828557.USD","LU2097828474.EUR","LU1023057109.AUD","LU1064131003.USD","BK0183","LU0405327148.USD","01276","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172293230","title":"Movement Alert｜HENGRUI PHARMA Rises 3.57% in Regular Trading, Multiple Global Institutions Accumulate Shares Amid Accelerated Drug Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=1172293230","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172293230?lang=en_us&edition=fundamental","pubTime":"2026-09-29 09:56","pubTimestamp":1790646971,"startTime":"0","endTime":"0","summary":"On September 29, HENGRUI PHARMA rose 3.57% in regular trading, trading at HK$46.1/share, with turnover of HK$34.26 million.The rally was driven by a wave of institutional accumulation from top global...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"UBS and BlackRock Boost Stakes in Hengrui Pharma","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670444684","title":"Blackrock's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 7.32%, Says HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2670444684","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670444684?lang=en_us&edition=fundamental","pubTime":"2026-09-25 18:31","pubTimestamp":1790332286,"startTime":"0","endTime":"0","summary":"BRIEF-Blackrock's Long Position In H-Shares Of Jiangsu Hengrui Pharmaceuticals Increases To 7.32%, Says HKEXSept 25 (Reuters)-HKEX:BLACKROCK'S LONG POSITION IN H-SHARES OF JIANGSU HENGRUI PHARMACEUTICALS INCREASES TO 7.32% ON SEPT 22 FROM 6.56%Further company coverage:1276.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45G1CT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","LU1255011170.USD","LU2289578879.USD","LU2488822045.USD","LU1781817850.SGD","LU2097828631.EUR","LU2097828714.EUR","LU1997245177.USD","LU2328871848.SGD","BK0012","LU2580892862.HKD","LU1328615791.USD","LU1064130708.USD","LU2097828805.USD","BK1191","LU1997245094.SGD","LU2495084118.USD","BK0028","BK0060","LU0405327494.USD","LU2148510915.USD","LU1655091616.SGD","LU1146622755.USD","LU0359201612.USD","LU1997244956.HKD","600276","BK0188","LU0359202008.SGD","LU1969619763.USD","LU0359201885.HKD","LU2580892789.USD","LU2543165471.USD","LU1580142542.USD","LU1820825898.SGD","LU2097828557.USD","LU2097828474.EUR","LU1023057109.AUD","LU1064131003.USD","BK0183","LU0405327148.USD","01276","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670419744","title":"UBS Group Ag's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 5.23% on Sept 21 from 4.43% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2670419744","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670419744?lang=en_us&edition=fundamental","pubTime":"2026-09-25 17:55","pubTimestamp":1790330133,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45G1CO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1023057109.AUD","LU1255011170.USD","LU2097828474.EUR","LU2097828557.USD","BK0060","LU2495084118.USD","BK0196","LU1328615791.USD","LU1580142542.USD","01276","BK0188","LU2148510915.USD","BK0183","LU1655091616.SGD","BK1191","LU0405327148.USD","LU1997244956.HKD","LU1969619763.USD","LU0359201885.HKD","LU2097828631.EUR","LU2097828714.EUR","LU1997245094.SGD","LU0405327494.USD","LU2580892789.USD","LU1064130708.USD","LU1997245177.USD","LU2289578879.USD","LU1146622755.USD","LU2328871848.SGD","LU1820825898.SGD","LU2543165471.USD","600276","LU0359201612.USD","BK0028","BK0012","LU0359202008.SGD","BK0239","LU1064131003.USD","LU2097828805.USD","LU2488822045.USD","LU2580892862.HKD","LU1781817850.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120302430","title":"HENGRUI PHARMA: UBS Group AG Acquires Shares, Long Position Rises to 5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1120302430","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120302430?lang=en_us&edition=fundamental","pubTime":"2026-09-25 17:15","pubTimestamp":1790327728,"startTime":"0","endTime":"0","summary":"UBS Group AG bought 2.07 million shares of HENGRUI PHARMA on the SEHK open market at an average of HKD 48.8574 per share on September 21, 2026, involving about HKD 100.98 million. This was an...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198751592","title":"HENGRUI PHARMA: BlackRock, Inc. Acquires Shares, Long Position Rises to 7.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198751592","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198751592?lang=en_us&edition=fundamental","pubTime":"2026-09-25 17:15","pubTimestamp":1790327719,"startTime":"0","endTime":"0","summary":"On September 22, 2026, BlackRock, Inc. acquired 1.96 million H shares of HENGRUI PHARMA by way of taking a security interest in shares. The transaction was an off-exchange deal with consideration...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182591067","title":"HENGRUI PHARMA: BlackRock, Inc. Disposes of Shares, Long Position Falls to 6.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1182591067","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182591067?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:37","pubTimestamp":1790242669,"startTime":"0","endTime":"0","summary":"On September 21, 2026, BlackRock, Inc. disposed of 1.82 million H shares of HENGRUI PHARMA (01276) by way of releasing a security interest (non-cash assets) in an off-exchange transaction, reducing...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155731676","title":"HENGRUI PHARMA: GIC Private Limited Disposes of Shares, Long Position Falls to 16.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155731676","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155731676?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:19","pubTimestamp":1790241543,"startTime":"0","endTime":"0","summary":"On September 21, 2026, GIC Private Limited sold 214,200 shares of HENGRUI PHARMA (01276) on the SEHK open market at an average of HKD 47.8372 per share, involving about HKD 10.25 million.Prior to the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}